β-lactamase inhibitors: then to now
Synairgen meets a development milestone with the commencement of dosing in hospitalised COVID-19 patients in its international Phase III trial of inhaled interferon beta
tranScrip announces the appointment of Kate Dawson
The Faculty of Pharmaceutical Medicine has published their survey report on 'Clinical Trials Resilience'
tranScrip welcomes Jo Cox as a Senior Partner
Hear what we're doing in lieu of travelling to San Francisco for Biotech Showcase and BIO at JP Morgan
BK virus: Combatting resurgence of a post-transplant opportunistic viral infection - A delicate balancing act
World Antimicrobial Awareness Week 2020